Louise Himmelstrup

Louise Himmelstrup has a diverse and extensive background in regulatory affairs within the pharmaceutical industry. Louise currently holds the position of Vice President EU Regulatory Affairs at Zevra Therapeutics since 2022. Prior to this, Louise worked at Orphazyme A/S, where they served as Head of Global Regulatory Affairs from 2021 to 2022 and as Director Global Regulatory Strategy in 2021. Louise also held the role of Senior Regulatory Lead from 2018 to 2021 at Orphazyme A/S.

Before joining Orphazyme A/S, Louise worked at LEO Pharma, starting in 2010. During their tenure, they held various positions, including Senior Regulatory Project Manager from 2015 to 2017, Regulatory Project Manager from 2013 to 2015, and Regulatory Affairs Professional from 2010 to 2013. In these roles, Louise was responsible for representing Regulatory Affairs in project core teams, leading regulatory focus teams, preparing regulatory strategies, participating in authority interactions, and providing input and reviewing documentation.

Louise's career in the pharmaceutical industry began at the Danish Medicines Agency, where they worked as a Regulatory Coordinator from 2009 to 2010 and as a Pharmacist from 2008 to 2009. Prior to that, they gained experience as a Pharmacist at Dalgas Boulevard Apotek in 2008 and as a Stud. Pharm at Roskilde Svane Apotek in 2007.

Additionally, Louise has academic experience, having worked as a Master Student in Cytokine Biology at Novo Nordisk from 2007 to 2008.

Overall, Louise Himmelstrup's work experience showcases their expertise in global regulatory affairs, project management, and leadership within the pharmaceutical industry.

From 2002 to 2008, Louise Himmelstrup attended the Faculty of Pharmaceutical Sciences at the University of Copenhagen, where they obtained their Cand. pharm degree.